Patient perceptions regarding the process of obtaining oral prostate cancer medications.

Authors

null

Eric B Schwartz

Kaiser Permanente, Lafayette, CO

Eric B Schwartz , Allison Furgal , Gina Widmer , Megan Veresh Caram , Christine M Veenstra

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 120)

DOI

10.1200/JCO.2023.41.6_suppl.120

Abstract #

120

Poster Bd #

E8

Abstract Disclosures

Similar Posters

First Author: Eric B Schwartz

Poster

2021 Genitourinary Cancers Symposium

Evaluating financial burdens of oral hormonal therapies for patients with prostate cancer.

Evaluating financial burdens of oral hormonal therapies for patients with prostate cancer.

First Author: Eric B Schwartz

Poster

2024 ASCO Genitourinary Cancers Symposium

Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.

Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.

First Author: David Joseph Benjamin

First Author: Alicia K. Morgans